Latest Biologic Stories
DALLAS, November 21, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Oncology Biosimilars Market 2014-2018 industry research report of 71 pages to the life science
MIAMI, Nov. 18, 2014 /PRNewswire/ -- Vivex Biomedical, Inc.
Treatment for lifelong skin disease that affects nearly a million Canadians showed significant and clinically meaningful improvements in clinical studies Canadian approval comes
Study finds that the Solstice-licensed technology allows efficient delivery of RNAi prodrugs SAN DIEGO, Nov.
EDISON, N.J., Nov.
Sales of Biologics Will Contribute Approximately $2.3 Billion to the UC Market in 2023, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
Brodalumab Meets All Primary and All Key Secondary Endpoints THOUSAND OAKS, Calif. and LONDON, Nov.
~Data to be presented at the American College of Rheumatology Annual Meeting CHARLOTTESVILLE, Va., Nov.
Company's collaborative partnership with IRICoR, Université de Montréal and MaRS Innovation, funded by Merck Canada, to advance macrocycle drug TORONTO and MONTREAL, Nov.
Drug Developers will Rely on Head-to-Head Clinical Trial Data Against Current Therapies to be Poised to Compete in the Increasingly Crowded TNF-alpha-Refractory Space BURLINGTON, Mass., Nov.
- A coin originally worth six pennies Scots, and later three; held equivalent to an English halfpenny.
- (in plural) Money; cash.